Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Kyprolis®(carfilzomib)
.
Show all posts
Showing posts with label
Kyprolis®(carfilzomib)
.
Show all posts
Friday, September 18, 2015
ASCO 2015: AMGEN presents new data evaluating less-frequent dosing of kyprolis for multiple myeloma patients
›
Amgen announced the initiation of the ARROW trial, a global Phase 3 study evaluating the benefit of Kyprolis ® (carfilzomib) for ...
›
Home
View web version
